NBIX·64125C109·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
NBIX (NEUROCRINE BIOSCIENCES INC) is held by 259 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.8B), DODGE & COX ($719.4M), JPMORGAN CHASE & CO ($700.5M). Net institutional sentiment: Mixed.
See how NBIX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer